Open AccessA double whammy in an immunocompromised patient
Author(s) -
Archana Bhatnagar,
Amandeep Singh,
Huliraj Narayanswamy,
Bhavya Shivalingaiah
Publication year - 2020
Publication title -
indian journal of sexually transmitted diseases and aids
Language(s) - English
Resource type - Journals
eISSN - 2589-0565
pISSN - 2589-0557
DOI - 10.4103/ijstd.ijstd_70_18
Subject(s) - medicine , immunosuppression , coinfection , pneumocystis jirovecii , cytomegalovirus , context (archaeology) , pneumonia , opportunistic infection , immunology , pulmonologists , pneumocystis pneumonia , aids related opportunistic infections , immunodeficiency , intensive care medicine , human immunodeficiency virus (hiv) , virology , immune system , sida , viral disease , herpesviridae , paleontology , biology
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection in immunocompromised patients, especially those with human immunodeficiency virus (HIV) infection. Cytomegalovirus (CMV) pneumonia most often occurs as a coinfection with another opportunistic pathogen especially in patients with severe immunosuppression. We present a case of PCP-CMV coinfection in a newly diagnosed HIV patient who was treated with the recommended therapy for both diseases and had a favorable outcome. The presence of CMV in the context of another opportunistic respiratory tract infection is often to be not treated, due to conflicting evidence of its therapeutic benefit. Our report highlights the importance of CMV treatment to achieve clinical stability and recovery in newly diagnosed patients with HIV and severely immuno-compromised status.